Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Pyxis Oncology Inc (NASDAQ: PYXS) was $4.09 for the day, down -2.39% from the previous closing price of $4.19. In other words, the price has decreased by -$2.39 from its previous closing price. On the day, 0.59 million shares were traded. PYXS stock price reached its highest trading level at $4.2494 during the session, while it also had its lowest trading level at $4.0464.
Ratios:
Our analysis of PYXS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 7.33 and its Current Ratio is at 7.33. In the meantime, Its Debt-to-Equity ratio is 0.13 whereas as Long-Term Debt/Eq ratio is at 0.12.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stephens on November 08, 2024, initiated with a Overweight rating and assigned the stock a target price of $13.
On August 08, 2024, Stifel started tracking the stock assigning a Buy rating and target price of $10.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PYXS now has a Market Capitalization of 243214720 and an Enterprise Value of 124883408. For the stock, the TTM Price-to-Sale (P/S) ratio is 14.74 while its Price-to-Book (P/B) ratio in mrq is 1.58. Its current Enterprise Value per Revenue stands at 7.735 whereas that against EBITDA is -2.039.
Stock Price History:
Over the past 52 weeks, PYXS has reached a high of $6.85, while it has fallen to a 52-week low of $1.35. The 50-Day Moving Average of the stock is 10.53%, while the 200-Day Moving Average is calculated to be 0.79%.
Shares Statistics:
PYXS traded an average of 530.37K shares per day over the past three months and 781120 shares per day over the past ten days. A total of 44.75M shares are outstanding, with a floating share count of 43.99M. Insiders hold about 25.98% of the company’s shares, while institutions hold 51.89% stake in the company. Shares short for PYXS as of 1730332800 were 5855879 with a Short Ratio of 11.04, compared to 1727654400 on 4223299. Therefore, it implies a Short% of Shares Outstanding of 5855879 and a Short% of Float of 11.97.
